CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishAIM: To evaluate a levofloxacin-doxycycline-based triple therapy with or without a susceptibility culture test in non-responders to Helicobacter pylori (H. pylori) eradication.METHODS: A total of 142 (99 women, 43 men; mean 53.0 +/- 12.7 years) non-responders to more than two H. pylori eradication therapies underwent susceptibility culture tests or were treated with a seven-day triple therapy consisting of esomeprazole, 20 mg b.i.d., levofloxacin, 500 mg b.i.d., and doxycycline, 100 mg b.i.d., randomly associated with (n = 71) or without (n = 71) Lactobacillus casei DG. H. pylori status was checked in all patients at enrollment and at least 8 wk after the end of therapy. Compliance and tolerability of regimens were also assessed.RESULTS: H. pylori eradication was achieved in < 50% of patients [ per prototol (PP) = 49%; intention to treat (ITT) = 46%]. Eradication rate was higher in patients administered probiotics than in those without (PP = 55% vs 43%; ITT = 54% vs 40%). Estimated primary resistance to levofloxacin was 18% and multiple resistance was 31%. Therapy was well tolerated, and side effects were generally mild, with only one patient experiencing severe effects.CONCLUSION: Third-line levofloxacin-doxycycline triple therapy had a low H. pylori eradication efficacy, though the success and tolerability of this treatment may be enhanced with probiotics.
Paoluzi, O.a., Del Vecchio Blanco, G., Visconti, E., Coppola, M., Fontana, C., Favaro, M., et al. (2015). Low efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy. WORLD JOURNAL OF GASTROENTEROLOGY, 21(21), 6698-6705.
| Tipologia: | Articolo su rivista |
| Citazione: | Paoluzi, O.a., Del Vecchio Blanco, G., Visconti, E., Coppola, M., Fontana, C., Favaro, M., et al. (2015). Low efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy. WORLD JOURNAL OF GASTROENTEROLOGY, 21(21), 6698-6705. |
| Lingua: | English |
| Settore Scientifico Disciplinare: | Settore MED/04 |
| Revisione (peer review): | Sì, ma tipo non specificato |
| Tipo: | Articolo |
| Rilevanza: | Rilevanza internazionale |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.3748/wjg.v21.i21.6698 |
| Stato di pubblicazione: | Pubblicato |
| Data di pubblicazione: | 7-giu-2015 |
| Titolo: | Low efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy |
| Autori: | |
| Autori: | Paoluzi, Oa; Del Vecchio Blanco, G; Visconti, E; Coppola, M; Fontana, C; Favaro, M; Pallone, F |
| Appare nelle tipologie: | 01 - Articolo su rivista |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| paoluziet al.pdf | Versione Editoriale (PDF) | Non specificato | UNIVERSITY_NETWORK Richiedi una copia |
Copyright © 2021